Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pamela Klingbeil

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Breast Cancer Research : BCR|September 3, 2011
The 'alternative' EMT switchPamela Klingbeil, Clare M Isacke
Mechanisms of Development|March 20, 2002
Xenopus marginal coil (Xmc), a novel FGF inducible cytosolic coiled-coil protein regulating gastrulation movementsGiovanni Frazzetto, Pamela Klingbeil, Tewis Bouwmeester
Experimental Cell Research|June 24, 2004
CD44 variant isoforms associate with tetraspanins and EpCAMDirk-Steffen Schmidt, Pamela Klingbeil, Martina Schnölzer, et al.
Molecular Cancer Research : MCR|February 12, 2009
CD44 variant isoforms promote metastasis formation by a tumor cell-matrix cross-talk that supports adhesion and apoptosis resistancePamela Klingbeil, Rachid Marhaba, Thorsten Jung, et al.
Current Molecular Medicine|December 17, 2008
CD44 and EpCAM: cancer-initiating cell markersRachid Marhaba, Pamela Klingbeil, Tobias Nuebel, et al.
Neoplasia (New York, N.Y.)|October 2, 2009
CD44v6 dependence of premetastatic niche preparation by exosomesThorsten Jung, Donatello Castellana, Pamela Klingbeil, et al.
Breast Cancer Research and Treatment|April 8, 2009
CD44 is overexpressed in basal-like breast cancers but is not a driver of 11p13 amplificationPamela Klingbeil, Rachael Natrajan, Gemma Everitt, et al.
Nature Communications|January 19, 2016
Tumour cell-derived Wnt7a recruits and activates fibroblasts to promote tumour aggressivenessAlexandra Avgustinova, Marjan Iravani, David Robertson, et al.
Molecular Cancer Research : MCR|June 21, 2007
A complex of EpCAM, claudin-7, CD44 variant isoforms, and tetraspanins promotes colorectal cancer progressionSebastian Kuhn, Moritz Koch, Tobias Nübel, et al.
Blood Cancer Journal|April 15, 2022
Validation of a small molecule inhibitor of PDE6D-RAS interaction with favorable anti-leukemic effectsSara Canovas Nunes, Serena De Vita, Andrew Anighoro, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Breast Cancer Research : BCR|September 3, 2011
The 'alternative' EMT switchPamela Klingbeil, Clare M Isacke
Mechanisms of Development|March 20, 2002
Xenopus marginal coil (Xmc), a novel FGF inducible cytosolic coiled-coil protein regulating gastrulation movementsGiovanni Frazzetto, Pamela Klingbeil, Tewis Bouwmeester
Experimental Cell Research|June 24, 2004
CD44 variant isoforms associate with tetraspanins and EpCAMDirk-Steffen Schmidt, Pamela Klingbeil, Martina Schnölzer, et al.
Molecular Cancer Research : MCR|February 12, 2009
CD44 variant isoforms promote metastasis formation by a tumor cell-matrix cross-talk that supports adhesion and apoptosis resistancePamela Klingbeil, Rachid Marhaba, Thorsten Jung, et al.
Current Molecular Medicine|December 17, 2008
CD44 and EpCAM: cancer-initiating cell markersRachid Marhaba, Pamela Klingbeil, Tobias Nuebel, et al.
Neoplasia (New York, N.Y.)|October 2, 2009
CD44v6 dependence of premetastatic niche preparation by exosomesThorsten Jung, Donatello Castellana, Pamela Klingbeil, et al.
Breast Cancer Research and Treatment|April 8, 2009
CD44 is overexpressed in basal-like breast cancers but is not a driver of 11p13 amplificationPamela Klingbeil, Rachael Natrajan, Gemma Everitt, et al.
Nature Communications|January 19, 2016
Tumour cell-derived Wnt7a recruits and activates fibroblasts to promote tumour aggressivenessAlexandra Avgustinova, Marjan Iravani, David Robertson, et al.
Molecular Cancer Research : MCR|June 21, 2007
A complex of EpCAM, claudin-7, CD44 variant isoforms, and tetraspanins promotes colorectal cancer progressionSebastian Kuhn, Moritz Koch, Tobias Nübel, et al.
Blood Cancer Journal|April 15, 2022
Validation of a small molecule inhibitor of PDE6D-RAS interaction with favorable anti-leukemic effectsSara Canovas Nunes, Serena De Vita, Andrew Anighoro, et al.
Pageof 1